Cipher Pharmaceuticals (CPH) Competitors

Cipher Pharmaceuticals (TSE:CPH) and Cronos Group (TSE:CRON) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

Do insiders & institutionals hold more shares of CPH or CRON?

1.4% of Cipher Pharmaceuticals shares are owned by institutional investors. Comparatively, 16.0% of Cronos Group shares are owned by institutional investors. 42.0% of Cipher Pharmaceuticals shares are owned by company insiders. Comparatively, 46.4% of Cronos Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Is CPH or CRON more profitable?

Cipher Pharmaceuticals has a net margin of 59.92% compared to Cronos Group's net margin of -42.65%. Cipher Pharmaceuticals' return on equity of 17.93% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cipher Pharmaceuticals	59.92%	17.93%	7.90%
Cronos Group	-42.65%	-4.40%	-3.73%

Does the media prefer CPH or CRON?

In the previous week, Cipher Pharmaceuticals had 1 more articles in the media than Cronos Group. MarketBeat recorded 1 mentions for Cipher Pharmaceuticals and 0 mentions for Cronos Group. Cipher Pharmaceuticals' average media sentiment score of 0.00 equaled Cronos Group'saverage media sentiment score.

Company	Overall Sentiment
Cipher Pharmaceuticals	Neutral
Cronos Group	Neutral

Which has more volatility & risk, CPH or CRON?

Cipher Pharmaceuticals has a beta of 1.2, suggesting that its stock price is 20% more volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500.

Do analysts recommend CPH or CRON?

Cipher Pharmaceuticals currently has a consensus target price of C$14.75, suggesting a potential upside of 14.25%. Given Cipher Pharmaceuticals' stronger consensus rating and higher probable upside, research analysts plainly believe Cipher Pharmaceuticals is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cipher Pharmaceuticals	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has better valuation & earnings, CPH or CRON?

Cipher Pharmaceuticals has higher earnings, but lower revenue than Cronos Group. Cronos Group is trading at a lower price-to-earnings ratio than Cipher Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cipher Pharmaceuticals	C$19.03M	12.18	C$11.41M	C$0.91	14.26
Cronos Group	C$76.86M	9.65	-C$32.78M	-C$0.18	-15.64

Summary

Cipher Pharmaceuticals beats Cronos Group on 13 of the 16 factors compared between the two stocks.